{
  "ptid_time": "033_S_6352_2018-05-11",
  "img_path": "/data/qiuhui/data/adni/images/033_S_6352/2018-05-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,121 mm³, 22.3% above the reference mean. With a Z-score of 0.54 (70.4th percentile), this represents normal volume ; hippocampal volume measures 8,734 mm³, 15.5% above the reference mean. With a Z-score of 1.52 (93.5th percentile), this represents moderate enlargement; whole brain volume measures 1,265,200 mm³, 17.2% above the reference mean. With a Z-score of 2.23 (98.7th percentile), this represents significant enlargement; entorhinal cortex volume measures 6,265 mm³, 52.8% above the reference mean. With a Z-score of 3.58 (100.0th percentile), this represents profound enlargement; fusiform gyrus volume measures 26,630 mm³, 41.4% above the reference mean. With a Z-score of 3.52 (100.0th percentile), this represents profound enlargement; middle temporal gyrus volume measures 26,068 mm³, 22.2% above the reference mean. With a Z-score of 1.99 (97.7th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 71.4 years. Gender is Male. Education: 20 years. Handedness: Left. Race: White. MMSE: 30.0. MoCA: 21.0. Logical Memory: 15.0. APOEε4 alleles: 1.0. Biomarker levels: Flobetaben (FBB): 1.00 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume data shows significant to profound enlargement in key regions (hippocampus, entorhinal cortex, fusiform gyrus, middle temporal gyrus), which is atypical for Alzheimer's disease (AD) where atrophy is expected. However, the MoCA score of 21 suggests cognitive impairment, while the MMSE of 30 is normal, creating a discrepancy. The presence of one APOE4 allele increases AD risk but does not confirm pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting imaging and cognitive findings—unexpected volumetric enlargement but clear MoCA impairment).  \n\n*Note:* The volumetric findings are highly unusual for neurodegenerative disease and may warrant further investigation (e.g., genetic or metabolic causes of brain enlargement). A follow-up clinical assessment focusing on non-AD etiologies (e.g., psychiatric, vascular, or inflammatory conditions) would be prudent.",
  "timestamp": "2025-07-26T05:40:21.505665"
}